6-K
MEDIROM Healthcare Technologies Inc. Receives Nasdaq Minimum Bid Price Notification
6-K
MEDIROM Healthcare Technologies Inc. Reports Q2 2026 Financial and Operational Results
6-K
MEDIROM Surpasses 50,000 Cumulative World ID Human Verifications
6-K
MEDIROM Healthcare Technologies Inc. Refinances Convertible Bonds into Loan Agreement
6-K
MEDIROM Healthcare Technologies Inc. Granted Nasdaq Compliance Extension
6-K
MEDIROM MOTHER Labs Expands "REMONY" Remote Health Monitoring System Deployment with JGSDF 8th Division